1. Home
  2. RCEL vs AOMR Comparison

RCEL vs AOMR Comparison

Compare RCEL & AOMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCEL
  • AOMR
  • Stock Information
  • Founded
  • RCEL N/A
  • AOMR 2018
  • Country
  • RCEL United States
  • AOMR United States
  • Employees
  • RCEL N/A
  • AOMR N/A
  • Industry
  • RCEL Medical/Dental Instruments
  • AOMR Real Estate Investment Trusts
  • Sector
  • RCEL Health Care
  • AOMR Real Estate
  • Exchange
  • RCEL Nasdaq
  • AOMR Nasdaq
  • Market Cap
  • RCEL 240.6M
  • AOMR 228.8M
  • IPO Year
  • RCEL N/A
  • AOMR 2021
  • Fundamental
  • Price
  • RCEL $6.97
  • AOMR $10.09
  • Analyst Decision
  • RCEL Strong Buy
  • AOMR Strong Buy
  • Analyst Count
  • RCEL 4
  • AOMR 6
  • Target Price
  • RCEL $17.25
  • AOMR $11.33
  • AVG Volume (30 Days)
  • RCEL 197.1K
  • AOMR 104.4K
  • Earning Date
  • RCEL 05-08-2025
  • AOMR 05-05-2025
  • Dividend Yield
  • RCEL N/A
  • AOMR 12.66%
  • EPS Growth
  • RCEL N/A
  • AOMR N/A
  • EPS
  • RCEL N/A
  • AOMR 1.51
  • Revenue
  • RCEL $71,661,000.00
  • AOMR $57,147,000.00
  • Revenue This Year
  • RCEL $62.33
  • AOMR N/A
  • Revenue Next Year
  • RCEL $30.59
  • AOMR $7.33
  • P/E Ratio
  • RCEL N/A
  • AOMR $6.69
  • Revenue Growth
  • RCEL 41.35
  • AOMR N/A
  • 52 Week Low
  • RCEL $6.90
  • AOMR $7.36
  • 52 Week High
  • RCEL $14.16
  • AOMR $13.32
  • Technical
  • Relative Strength Index (RSI)
  • RCEL 28.06
  • AOMR 70.65
  • Support Level
  • RCEL $9.50
  • AOMR $9.40
  • Resistance Level
  • RCEL $9.85
  • AOMR $9.90
  • Average True Range (ATR)
  • RCEL 0.53
  • AOMR 0.34
  • MACD
  • RCEL -0.20
  • AOMR 0.18
  • Stochastic Oscillator
  • RCEL 10.03
  • AOMR 97.56

About RCEL Avita Medical Inc.

Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult patients in the US with paediatric clinical trials and expanded indications in soft-tissue reconstruction and vitiligo underway. It is currently in roll-out across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.

About AOMR Angel Oak Mortgage REIT Inc.

Angel Oak Mortgage REIT Inc is a real estate finance company focused on acquiring and investing in the first lien non-QM loans and other mortgage-related assets in the U.S. mortgage market. Its objective is to generate attractive risk-adjusted returns for its stockholders, through cash distributions and capital appreciation, across interest rates and credit cycles.

Share on Social Networks: